BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22364313)

  • 1. Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans.
    Bolscher J; Nazmi K; van Marle J; van 't Hof W; Veerman E
    Biochem Cell Biol; 2012 Jun; 90(3):378-88. PubMed ID: 22364313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.
    Bolscher JG; Adão R; Nazmi K; van den Keybus PA; van 't Hof W; Nieuw Amerongen AV; Bastos M; Veerman EC
    Biochimie; 2009 Jan; 91(1):123-32. PubMed ID: 18573310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part.
    van der Kraan MI; Nazmi K; Teeken A; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Biol Chem; 2005 Feb; 386(2):137-42. PubMed ID: 15843157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
    van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284.
    van der Kraan MI; van der Made C; Nazmi K; van't Hof W; Groenink J; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Nov; 26(11):2093-7. PubMed ID: 15946771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
    Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural diversity and mode of action on lipid membranes of three lactoferrin candidacidal peptides.
    Silva T; Adão R; Nazmi K; Bolscher JG; Funari SS; Uhríková D; Bastos M
    Biochim Biophys Acta; 2013 May; 1828(5):1329-39. PubMed ID: 23384417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lactoferrin derived peptides on simulants of biological warfare agents.
    Sijbrandij T; Ligtenberg AJ; Nazmi K; Veerman EC; Bolscher JG; Bikker FJ
    World J Microbiol Biotechnol; 2017 Jan; 33(1):3. PubMed ID: 27832504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.
    Tanida T; Okamoto T; Ueta E; Yamamoto T; Osaki T
    J Antimicrob Chemother; 2006 Jan; 57(1):94-103. PubMed ID: 16291868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin.
    León-Sicairos N; Angulo-Zamudio UA; Vidal JE; López-Torres CA; Bolscher JG; Nazmi K; Reyes-Cortes R; Reyes-López M; de la Garza M; Canizalez-Román A
    Biometals; 2014 Oct; 27(5):969-80. PubMed ID: 25053107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
    van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin.
    Silva T; Abengózar MÁ; Fernández-Reyes M; Andreu D; Nazmi K; Bolscher JG; Bastos M; Rivas L
    Amino Acids; 2012 Dec; 43(6):2265-77. PubMed ID: 22543751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin and lactoferrin chimera inhibit damage caused by enteropathogenic Escherichia coli in HEp-2 cells.
    Flores-Villaseñor H; Canizalez-Román A; de la Garza M; Nazmi K; Bolscher JG; Leon-Sicairos N
    Biochimie; 2012 Sep; 94(9):1935-42. PubMed ID: 22640957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus.
    Leon-Sicairos N; Canizalez-Roman A; de la Garza M; Reyes-Lopez M; Zazueta-Beltran J; Nazmi K; Gomez-Gil B; Bolscher JG
    Biochimie; 2009 Jan; 91(1):133-40. PubMed ID: 18625283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human lactoferrin on the cytoplasmic membrane of Candida albicans cells related with its candidacidal activity.
    Viejo-Díaz M; Andrés MT; Fierro JF
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):181-5. PubMed ID: 15364102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
    Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
    Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-active mechanism of LFchimera against Burkholderia pseudomallei and Burkholderia thailandensis.
    Kanthawong S; Puknun A; Bolscher JG; Nazmi K; van Marle J; de Soet JJ; Veerman EC; Wongratanacheewin S; Taweechaisupapong S
    Biometals; 2014 Oct; 27(5):949-56. PubMed ID: 24961697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
    Viejo-Díaz M; Andrés MT; Fierro JF
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2583-8. PubMed ID: 15980323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin.
    Haney EF; Nazmi K; Bolscher JG; Vogel HJ
    Biochim Biophys Acta; 2012 Mar; 1818(3):762-75. PubMed ID: 22155682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.